BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 22211865)

  • 1. Striatal NTS1 , dopamine D2 and NMDA receptor regulation of pallidal GABA and glutamate release--a dual-probe microdialysis study in the intranigral 6-hydroxydopamine unilaterally lesioned rat.
    Ferraro L; O'Connor WT; Beggiato S; Tomasini MC; Fuxe K; Tanganelli S; Antonelli T
    Eur J Neurosci; 2012 Jan; 35(2):207-20. PubMed ID: 22211865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of intrastriatal neurotensin(1-13) and neurotensin(8-13) on striatal dopamine and pallidal GABA release. A dual-probe microdialysis study in the awake rat.
    Ferraro L; O'Connor WT; Antonelli T; Fuxe K; Tanganelli S
    Eur J Neurosci; 1997 Sep; 9(9):1838-46. PubMed ID: 9383206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NR2A and NR2B subunit containing NMDA receptors differentially regulate striatal output pathways.
    Fantin M; Marti M; Auberson YP; Morari M
    J Neurochem; 2007 Dec; 103(6):2200-11. PubMed ID: 17986236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional role of striatal A2A, D2, and mGlu5 receptor interactions in regulating striatopallidal GABA neuronal transmission.
    Beggiato S; Tomasini MC; Borelli AC; Borroto-Escuela DO; Fuxe K; Antonelli T; Tanganelli S; Ferraro L
    J Neurochem; 2016 Jul; 138(2):254-64. PubMed ID: 27127992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The striatal neurotensin receptor modulates striatal and pallidal glutamate and GABA release: functional evidence for a pallidal glutamate-GABA interaction via the pallidal-subthalamic nucleus loop.
    Ferraro L; Antonelli T; O'Connor WT; Fuxe K; Soubrié P; Tanganelli S
    J Neurosci; 1998 Sep; 18(17):6977-89. PubMed ID: 9712666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotensin regulates cortical glutamate transmission by modulating N-methyl-D-aspartate receptor functional activity: an in vivo microdialysis study.
    Ferraro L; Beggiato S; Tomasini MC; Fuxe K; Tanganelli S; Antonelli T
    J Neurosci Res; 2011 Oct; 89(10):1618-26. PubMed ID: 21656844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal plasticity at the network level. Focus on adenosine A2A and D2 interactions in models of Parkinson's Disease.
    Tanganelli S; Sandager Nielsen K; Ferraro L; Antonelli T; Kehr J; Franco R; Ferré S; Agnati LF; Fuxe K; Scheel-Krüger J
    Parkinsonism Relat Disord; 2004 Jul; 10(5):273-80. PubMed ID: 15196505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
    McPherson RJ; Marshall JF
    Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine A(2A) receptor-mediated modulation of GABA and glutamate release in the output regions of the basal ganglia in a rodent model of Parkinson's disease.
    Ochi M; Shiozaki S; Kase H
    Neuroscience; 2004; 127(1):223-31. PubMed ID: 15219684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels.
    Mela F; Marti M; Bido S; Cenci MA; Morari M
    Neurobiol Dis; 2012 Jan; 45(1):573-82. PubMed ID: 22001605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of NR2A and NR2B subunit selective NMDA receptor antagonists on striato-pallidal neurons: relationship to motor response in the 6-hydroxydopamine model of parkinsonism.
    Fantin M; Auberson YP; Morari M
    J Neurochem; 2008 Jul; 106(2):957-68. PubMed ID: 18435828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor function.
    Morari M; O'Connor WT; Ungerstedt U; Bianchi C; Fuxe K
    Neuroscience; 1996 May; 72(1):89-97. PubMed ID: 8730708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMDA-mediated release of glutamate and GABA in the subthalamic nucleus is mediated by dopamine: an in vivo microdialysis study in rats.
    Ampe B; Massie A; D'Haens J; Ebinger G; Michotte Y; Sarre S
    J Neurochem; 2007 Nov; 103(3):1063-74. PubMed ID: 17727638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental studies and theoretical aspects on A2A/D2 receptor interactions in a model of Parkinson's disease. Relevance for L-dopa induced dyskinesias.
    Antonelli T; Fuxe K; Agnati L; Mazzoni E; Tanganelli S; Tomasini MC; Ferraro L
    J Neurol Sci; 2006 Oct; 248(1-2):16-22. PubMed ID: 16765381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine.
    Marti M; Manzalini M; Fantin M; Bianchi C; Della Corte L; Morari M
    J Neurochem; 2005 Apr; 93(1):195-205. PubMed ID: 15773919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
    Carta AR; Frau L; Pinna A; Pontis S; Simola N; Schintu N; Morelli M
    Synapse; 2008 Jul; 62(7):524-33. PubMed ID: 18435422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of the preferential control over the striato-nigral direct pathway by striatal NMDA receptors in a rat model of Parkinson's disease.
    Morari M; Fantin M
    Analyst; 2015 Jun; 140(11):3830-9. PubMed ID: 25584655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional neuroanatomy of the ventral striopallidal GABA pathway. New sites of intervention in the treatment of schizophrenia.
    O'Connor WT
    J Neurosci Methods; 2001 Aug; 109(1):31-9. PubMed ID: 11489297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-receptor interactions as studied with microdialysis. Focus on NTR/D2 interactions in the basal ganglia.
    Antonelli T; Tomasini MC; Fuxe K; Agnati LF; Tanganelli S; Ferraro L
    J Neural Transm (Vienna); 2007 Jan; 114(1):105-13. PubMed ID: 16983483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A(2A) and dopamine D(2) receptors.
    Díaz-Cabiale Z; Vivó M; Del Arco A; O'Connor WT; Harte MK; Müller CE; Martínez E; Popoli P; Fuxe K; Ferré S
    Neurosci Lett; 2002 May; 324(2):154-8. PubMed ID: 11988350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.